China A-share CRO sector rebounded from intraday losses; Ruizhi Pharma rose over 12%, Dongfang Haiyang hit the daily limit, Jin'an Protein gained nearly 11%, Wanbang Pharma, Baihua Pharma and Puruisi also advanced.

At its 2026 Q3 results briefing, Yili said upstream supply and demand have steadily improved year-to-date and industry contract milk prices rose slightly YoY in Q3 as conditions moved toward balance. Looking to next year, the company expects packaged dairy demand to recover modestly and domestic substitution in deep-processed dairy to continue, supporting a likely mild rebound in contract milk prices and a return to a healthier, more rational industry dynamic.

英國首相發言人：政府將在下屆選舉前推進福利改革。首相伯納姆與財政大臣希利認爲福利法案需要削減。